134 related articles for article (PubMed ID: 31239768)
1. Association of caveolin-1 protein expression with hepatocellular carcinoma: a meta-analysis and literature review.
Zhang Y; Fan W; Wu J; Dong J; Cui Z
Cancer Manag Res; 2019; 11():5113-5122. PubMed ID: 31239768
[No Abstract] [Full Text] [Related]
2. Expression and significance of caveolin-1 in hepatitis B virus-associated hepatocellular carcinoma.
Cheng H; Pan Y; Yao Y; Zhu Z; Chen J; Sun X; Qiu Y; Ding Y
Exp Ther Med; 2017 Nov; 14(5):4356-4362. PubMed ID: 29067114
[TBL] [Abstract][Full Text] [Related]
3. Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism.
Chai F; Li Y; Liu K; Li Q; Sun H
J Cell Physiol; 2019 Feb; 234(2):1937-1946. PubMed ID: 30144070
[TBL] [Abstract][Full Text] [Related]
4. The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma.
Hsu CM; Yang MD; Tsai CW; Ho CY; Chang WS; Chang SC; Jeng LB; Tsai Y; Tsai FJ; Bau DT
Anticancer Res; 2013 Feb; 33(2):671-7. PubMed ID: 23393366
[TBL] [Abstract][Full Text] [Related]
5. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
Zhou L; Zhu Y
Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic significance of
Wu X; Yao X; Cao Q; Wu Z; Wang Z; Liu F; Shen L
Cancer Manag Res; 2019; 11():857-864. PubMed ID: 30697077
[TBL] [Abstract][Full Text] [Related]
7. The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.
Zhang L; Han J; Wu H; Liang X; Zhang J; Li J; Xie L; Xie Y; Sheng X; Yu J
PLoS One; 2014; 9(10):e110626. PubMed ID: 25356587
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of caveolin-1 expression in gastric cancer: a meta-analysis.
Ye Y; Miao SH; Lu RZ; Zhou JW
Asian Pac J Cancer Prev; 2014; 15(19):8367-70. PubMed ID: 25339030
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of caveolin in breast cancer: a meta-analysis.
Ma X; Liu L; Nie W; Li Y; Zhang B; Zhang J; Zhou R
Breast; 2013 Aug; 22(4):462-9. PubMed ID: 23639584
[TBL] [Abstract][Full Text] [Related]
12. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and prognostic significance of high Ki-67 labeling index in hepatocellular carcinoma patients: a meta-analysis.
Luo Y; Ren F; Liu Y; Shi Z; Tan Z; Xiong H; Dang Y; Chen G
Int J Clin Exp Med; 2015; 8(7):10235-47. PubMed ID: 26379815
[TBL] [Abstract][Full Text] [Related]
15. Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.
Zhang S; Wu H; Wu X; Lian W; Wang Y; Zhang X; Peng X
Int J Clin Exp Med; 2015; 8(5):6638-49. PubMed ID: 26221201
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
Du ZM; Hu CF; Shao Q; Huang MY; Kou CW; Zhu XF; Zeng YX; Shao JY
Int J Cancer; 2009 Oct; 125(8):1832-41. PubMed ID: 19582878
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Liang C; Zhang K; Ge H; Li W; Li G; Wu J
Clin Chim Acta; 2018 Feb; 477():24-31. PubMed ID: 29198990
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.
Zhong C; Wu JD; Fang MM; Pu LY
Tumour Biol; 2015 Sep; 36(10):7623-30. PubMed ID: 25921286
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of EMT-inducing transcription factors as a potential poor prognostic factor for hepatocellular carcinoma in Asian populations: A meta-analysis.
Wan T; Zhang T; Si X; Zhou Y
Oncotarget; 2017 Aug; 8(35):59500-59508. PubMed ID: 28938653
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
Front Immunol; 2018; 9():2077. PubMed ID: 30254644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
